EUropean Real-world Experience Of Previously Treated Advanced/Metastatic HER2-positive Breast Cancer Patients Accessing Trastuzumab Deruxtecan
Clinical trial NCT05458401 · COMPLETED
Trial details
- NCT number
- NCT05458401
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-11-11
- Primary completion
- 2023-12-01
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.